Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 632 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
B. L. Strom, Schinnar, R., Apter, A. J., Margolis, D. J., Lautenbach, E., Hennessy, S., Bilker, W. B., and Pettitt, D., Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics, N Engl J Med, vol. 349, pp. 1628-35, 2003.
A. M. Gallagher, Dedman, D., Padmanabhan, S., Leufkens, H. G. M., and de Vries, F., The accuracy of date of death recording in the Clinical Practice Research Datalink GOLD database in England compared with the Office for National Statistics death registrations, Pharmacoepidemiol Drug Saf, 2019.
K. D. Johnson, Lu, X., and Zhang, D., Adherence to hepatitis A and hepatitis B multi-dose vaccination schedules among adults in the United Kingdom: a retrospective cohort study, BMC Public Health, vol. 19, p. 404, 2019.
K. Jameson, D'Oca, K., Murray-Thomas, T., O'Regan, C., and Leigh, P., Adherence to Nice Guidance For Initiating Glp-1 Mimetics Among Patients With Type 2 Diabetes In Primary Care In England And Wales - An Evaluation Using The Clinical Practice Research Datalink (Cprd), Value Health, vol. 17, p. A362, 2014.
K. Jameson, D'Oca, K., Leigh, P., and Murray-Thomas, T., Adherence to NICE guidance on glucagon-like peptide-1 receptor agonists among patients with type 2 diabetes mellitus: an evaluation using the Clinical Practice Research Datalink, Curr Med Res Opin, vol. 32, pp. 49-60, 2016.
A. J. Farmer, Rodgers, L. R., Lonergan, M., Shields, B., Weedon, M. N., Donnelly, L., Holman, R. R., Pearson, E. R., and Hattersley, A. T., Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database, Diabetes Care, vol. 39, pp. 258-263, 2016.
M. J. Crowther, Lambert, P. C., and Abrams, K. R., Adjusting for measurement error in baseline prognostic biomarkers included in a time-to-event analysis: a joint modelling approach, BMC Med Res Methodol, vol. 13, p. 146, 2013.
S. B. Meropol, Chan, K. A., Chen, Z., Finkelstein, J. A., Hennessy, S., Lautenbach, E., Platt, R., Schech, S. D., Shatin, D., and Metlay, J. P., Adverse events associated with prolonged antibiotic use, Pharmacoepidemiol Drug Saf, vol. 17, pp. 523-32, 2008.
M. Ashworth, Charlton, J., Latinovic, R., and Gulliford, M., Age-related changes in consultations and antibiotic prescribing for acute respiratory infections, 1995-2000. Data from the UK General Practice Research Database, J Clin Pharm Ther, vol. 31, pp. 461-7, 2006.
J. D. Lewis and Brensinger, C., Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey, Pharmacoepidemiol Drug Saf, vol. 13, pp. 437-41, 2004.
R. Jones, Charlton, J., Latinovic, R., and Gulliford, M. C., Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study, Bmj, vol. 339, p. b3094, 2009.
R. Jones, Latinovic, R., Charlton, J., and Gulliford, M. C., Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database, Bmj, vol. 334, p. 1040, 2007.
S. de Lusignan, Liaw, S. T., Dedman, D., Khunti, K., Sadek, K., and Jones, S., An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR), J Innov Health Inform, vol. 22, pp. 255-64, 2015.
S. S. Soedamah-Muthu, Fuller, J. H., Mulnier, H. E., Raleigh, V. S., Lawrenson, R. A., and Colhoun, H. M., All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999, Diabetologia, vol. 49, pp. 660-6, 2006.
F. Lapi, Azoulay, L., Niazi, M. T., Yin, H., Benayoun, S., and Suissa, S., Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer, Jama, vol. 310, pp. 289-96, 2013.
E. M. van de Garde, Souverein, P. C., Hak, E., Deneer, V. H., van den Bosch, J. M., and Leufkens, H. G., Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes, J Hypertens, vol. 25, pp. 235-9, 2007.
R. Hubbard, Venn, A., Lewis, S., and Britton, J., Anitdepressant exposure and risk of Cryptogenic Fibrosing Alveolitis (CFA): A case-control study using the General Practice Research Database (GPRD), vol. 53, p. A11, 1998.
R. A. Lawrenson and Logie, J. W., Antibiotic failure in the treatment of urinary tract infections in young women, J Antimicrob Chemother, vol. 48, pp. 895-901, 2001.
R. A. Lawrenson and Logie, J. W., Antibiotic failure in the treatment of urinary tract infections in young women, J Antimicrob Chemother, vol. 48, pp. 895-901, 2001.
M. Gharbi, Drysdale, J. H., Lishman, H., Goudie, R., Molokhia, M., Johnson, A. P., Holmes, A. H., and Aylin, P., Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study, Bmj, vol. 364, p. l525, 2019.
C. Hopkins, Williamson, E., Morris, S., Clarke, C. S., Thomas, M., Evans, H., Little, P., Lund, V. J., Blackshaw, H., Schilder, A., Philpott, C., Carpenter, J., and Denaxas, S., Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records, Rhinology, 2019.
C. Hopkins, Williamson, E., Morris, S., Clarke, C. S., Thomas, M., Evans, H., Little, P., Lund, V. J., Blackshaw, H., Schilder, A., Philpott, C., Carpenter, J., and Denaxas, S., Antibiotic usage in chronic rhinosinusitis: analysis of national primary care electronic health records, Rhinology, 2019.
T. Card, Logan, R. F., Rodrigues, L. C., and Wheeler, J. G., Antibiotic use and the development of Crohn's disease, Gut, vol. 53, pp. 246-50, 2004.
F. N. Aberra, Brensinger, C. M., Bilker, W. B., Lichtenstein, G. R., and Lewis, J. D., Antibiotic use and the risk of flare of inflammatory bowel disease, Clin Gastroenterol Hepatol, vol. 3, pp. 459-65, 2005.
F. N. Aberra, Brensinger, C. M., Bilker, W. B., Lichtenstein, G. R., and Lewis, J. D., Antibiotic use and the risk of flare of inflammatory bowel disease, Clin Gastroenterol Hepatol, vol. 3, pp. 459-65, 2005.
K. Richardson, Fox, C., Maidment, I., Steel, N., Loke, Y. K., Arthur, A., Myint, P. K., Grossi, C. M., Mattishent, K., Bennett, K., Campbell, N. L., Boustani, M., Robinson, L., Brayne, C., Matthews, F. E., and Savva, G. M., Anticholinergic drugs and risk of dementia: case-control study, Bmj, vol. 361, p. k1315, 2018.
S. S. Jick and Li, L., Antidepressant drug use and risk of venous thromboembolism, Pharmacotherapy, vol. 28, pp. 144-50, 2008.
V. Abbing-Karahagopian, Huerta, C., Souverein, P. C., de Abajo, F., Leufkens, H. G., Slattery, J., Alvarez, Y., Miret, M., Gil, M., Oliva, B., Hesse, U., Requena, G., de Vries, F., Rottenkolber, M., Schmiedl, S., Reynolds, R., Schlienger, R. G., de Groot, M. C., Klungel, O. H., van Staa, T. P., van Dijk, L., Egberts, A. C., Gardarsdottir, H., and De Bruin, M. L., Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications, Eur J Clin Pharmacol, vol. 70, pp. 849-57, 2014.
S. R. Heckbert, Wiggins, K. L., Glazer, N. L., Dublin, S., Psaty, B. M., Smith, N. L., Longstreth, Jr., W. T., and Lumley, T., Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population, Am J Hypertens, vol. 22, pp. 538-44, 2009.
S. R. Heckbert, Wiggins, K. L., Glazer, N. L., Dublin, S., Psaty, B. M., Smith, N. L., Longstreth, Jr., W. T., and Lumley, T., Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population, Am J Hypertens, vol. 22, pp. 538-44, 2009.
C. Klop, Gibson-Smith, D., Elders, P. J., Welsing, P. M., Leufkens, H. G., Harvey, N. C., Bijlsma, J. W., van Staa, T. P., and de Vries, F., Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010, Osteoporos Int, vol. 26, pp. 1919-28, 2015.
S. Hawley, Leal, J., Delmestri, A., Prieto-Alhambra, D., Arden, N. K., Cooper, C., Javaid, M. K., and Judge, A., Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis, J Bone Miner Res, vol. 31, pp. 2008-2015, 2016.
C. Ishiguro, Wang, X., Li, L., and Jick, S., Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case-control study using the CPRD, Pharmacoepidemiol Drug Saf, vol. 23, pp. 1168-75, 2014.
A. K. Ali, Hartzema, A. G., Winterstein, A. G., Segal, R., Lu, X., and Hendeles, L., Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink, Value Health, vol. 18, pp. 260-70, 2015.
T. P. van Staa, Bishop, N., Leufkens, H. G., and Cooper, C., Are inhaled corticosteroids associated with an increased risk of fracture in children?, Osteoporos Int, vol. 15, pp. 785-91, 2004.
A. Leite, Andrews, N. J., and Thomas, S. L., Assessing recording delays in general practice records to inform near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD), Pharmacoepidemiol Drug Saf, vol. 26, pp. 437-445, 2017.
C. E. Koro, Fedder, D. O., L'Italien, G. J., Weiss, S. S., Magder, L. S., Kreyenbuhl, J., Revicki, D. A., and Buchanan, R. W., Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study, Bmj, vol. 325, p. 243, 2002.
C. E. Koro, Fedder, D. O., L'Italien, G. J., Weiss, S., Magder, L. S., Kreyenbuhl, J., Revicki, D., and Buchanan, R. W., An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients, Arch Gen Psychiatry, vol. 59, pp. 1021-6, 2002.
L. Alexandre, Clark, A. B., Bhutta, H. Y., Chan, S. S., Lewis, M. P., and Hart, A. R., Association Between Statin Use After Diagnosis of Esophageal Cancer and Survival: A Population-Based Cohort Study, Gastroenterology, vol. 150, pp. 854-65.e1; quiz e16-7, 2016.
R. Williams, Kothny, W., Serban, C., Lopez-Leon, S., de Vries, F., and Schlienger, R., Association between vildagliptin and risk of angioedema, foot ulcers, skin lesions, hepatic toxicity, and serious infections in patients with type 2 diabetes mellitus: A European multidatabase, noninterventional, postauthorization safety study, Endocrinol Diabetes Metab, vol. 2, p. e00084, 2019.
L. Li, Ambegaonkar, B. M., Reckless, J. P., and Jick, S., Association of a reduction in low-density lipoprotein cholesterol with incident cardiovascular and cerebrovascular events among people with type 2 diabetes mellitus, Eur J Prev Cardiol, vol. 21, pp. 855-65, 2014.
F. Montastruc, Nie, R., Loo, S., Rej, S., Dell'Aniello, S., Micallef, J., Suissa, S., and Renoux, C., Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide, JAMA Psychiatry, 2019.
[Page last reviewed 4 October 2019]